MD Medical Group "Mother and Child" Russia Moscow — Group of companies "Mother and child"
en

Investment case

Vertically integrated business model strengthened by educational initiatives
  • Synergies from the cross-utilisation of different medical facility formats
  • Training of medical staff through an in-house educational facility
52

clinics

11

hospitals

63

medical facilities

Effective growth strategy
10

medical facilities

2012

63

medical facilities

2024

Multidisciplinary care
  • Developing new healthcare service profiles
Geography
  • Strengthening market position across the regions of operation
  • Pursuing growth in new regions
Efficiency
  • Increasing utilisation rates at the existing facilities
  • Promoting efficient pricing policies
  • Cutting costs
Quality
  • Consistent efforts to improve the quality of services
  • Broad availability of hi-tech equipment
  • Championing digitalisation
62

medical facilities

2024

Revenue dynamics, Rub bn

High standards of medical care, brand recognition
  • Highly skilled medical staff with years of experience, including high-level certified medical practitioners, PhDs and post-doctoral degrees in medical sciences
  • State-of-the-art medical equipment from the leading manufacturers
  • Strong digitalisation in healthcare
A wide range of healthcare services
  • Full lifecycle assistance (from birth and throughout life)
  • No. 1 in the realm of women’s and children’s healthcare
  • Competencies in the most popular areas, including oncology, traumatology, cardiology, and surgery
78

areas of medical expertise

Revenue structure

  • Women's and Children's health — 57%
  • IVF — 32%
    OBGYN — 29%
    Deliveries — 23%
    Pediatrics — 16%
  • Surgery, cardiology  and traumatology — 11%
  • Medical-Diagnostic centre — 11%
  • Oncology — 9%
  • Laboratory examinations —5%
  • Therapy — 4%
  • Other revenue — 3%
Extensive geography
  • A unique company with strong presence across Russia
  • Efficient routing of patient flows
  • High profitability of services both in Moscow and in other regions
30

regions

37

cities

63

medical facilities

Revenue structure

Flexible pricing
  • Flexible pricing policy depending on the region and format of medical facilities

Revenue by payers

Attractive market fundamentals
  • Fragmented market with consolidation opportunities for big players
  • High entry barriers
  • Government support for private healthcare providers:
    • 0% income tax
    • Availability of medical services under MHI programmes
    • Permanent medical licensing
Professional management team highly motivated for the Company’s growth
Dr. Mark Kurtser
PhD, Member of Russian Academy of Science — CEO and Member of the Board of Directors
Alexander Kotov
First Deputy CEO
Dr. Natalia Butkevich
PhD — Medical Director, Head of clinical hospitals
Iya Lukyanova
Chief Financial Officer
Pavel Rudnikov
Chief Commercial Officer
Dr. Yulia Kutakova
PhD — Medical Director for Organizational and Scientific-educational Work
High margins and strong financial position
Revenue Rub27.6 bn for 2023
EBITDA Rub9.2 bn for 2023
Profit up to 100% may be allocated to dividends
Net cash position Rub9 bn as at 31.12.2023